title: [Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment].
authors.affiliation: Klinik für Neurologie, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Deutschland. hajo.hamer@uk-erlangen.de.
authors.forename: H
authors.initials: H
authors.lastname: Hamer
authors.affiliation: Zentralinstitut für seelische Gesundheit, Klinik für Psychiatrie und Psychotherapie, Universität Heidelberg/Medizinische Fakultät Mannheim, 68159, Mannheim, Deutschland. a.meyer-lindenberg@zi-mannheim.de.
authors.forename: A
authors.initials: A
authors.lastname: Meyer-Lindenberg
mesh_terms: D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D005858:Germany; D033161:Government Regulation; D018166:Health Care Reform / Q000191:economics / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug; D008389:Marketing of Health Services / Q000191:economics / Q000331:legislation & jurisprudence*; D009462:Neurology / Q000191:economics / Q000331:legislation & jurisprudence; D017063:Outcome Assessment, Health Care / Q000191:economics / Q000331:legislation & jurisprudence*; D011613:Psychotherapy / Q000191:economics / Q000331:legislation & jurisprudence; D011785:Quality Assurance, Health Care / Q000191:economics / Q000331:legislation & jurisprudence*